CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Open-market buy Director bought 5,000 shares at $1.90 ($9,500)
- 4 Open-market buy CEO bought 1,250 shares at $1.89 ($2,360)
- 4 Open-market buy Director bought 5,300 shares at $1.89 ($10,010)
- 4 Open-market buy Director bought 5,500 shares at $1.87 ($10,285)
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Agreement ended
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 9,091 shares at $5.49 ($49,910)
- 4 Open-market buy Director bought 1,819 shares at $5.49 ($9,986)
- 4 Open-market buy Director bought 28,000 shares at $5.49 ($153,720)
- 4 Open-market buy Director bought 9,091 shares at $5.49 ($49,910)
- 4 Open-market buy Director bought 5,000 shares at $5.49 ($27,450)
- 8-K Event Material agreement · Delisting notice
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
Page 12 of 17 · 328 filings